Journal article icon

Journal article

Beta Agonist Lung Injury TrIal-2 (BALTI-2) trial protocol: a randomised, double-blind, placebo-controlled of intravenous infusion of salbutamol in the acute respiratory distress syndrome.

Abstract:

BACKGROUND: The acute respiratory distress syndrome (ARDS) is a common cause of respiratory failure in critically ill patients. Experimental studies suggest that treatment with beta agonists may be helpful in ARDS. The Beta Agonist Lung Injury TrIal (BALTI-2) is a multicentre, pragmatic, randomised, double-blind, placebo-controlled clinical trial which aims to determine if sustained treatment with intravenous (IV) salbutamol will improve survival in ARDS. METHODS/DESIGN: Patients fulfilling t...

Expand abstract
Publication status:
Published

Actions


Access Document


Publisher copy:
10.1186/1745-6215-12-113

Authors


More by this author
Institution:
University of Oxford
Department:
Oxford, MSD, NDORMS
Role:
Author
Expand authors...
Journal:
Trials
Volume:
12
Issue:
1
Pages:
113
Publication date:
2011-01-01
DOI:
EISSN:
1745-6215
ISSN:
1745-6215
URN:
uuid:70469cd1-e958-4bab-b959-889985270c6c
Source identifiers:
155439
Local pid:
pubs:155439

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP